-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
EURBörse Börse Frankfurt-
EUROcugen IncBörse Börse Frankfurt
-
EUROcugen IncBörse Börse Berlin
-
OCUGEN INCBörse Börse HamburgEURSymbol 2H51
-
OCUGEN INCBörse Gettex System der Börse MünchenEURSymbol 2H51
-
OCUGEN INCBörse Quotrix System der Börse DüsseldorfEURSymbol 2H51
-
OCUGEN INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 2H51
-
Ocugen IncBörse NasdaqISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
ISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
MXN
-
Firmenname
Ocugen, Inc
Marktkapitalisierung
2.426.421.568 (+- 21%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.922.843.136 oder 2.930.000.000
Mitarbeiter
50 (+- 68%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
16 oder 84 Mitarbeiter
KGV
0.08
EBITDA -15.215.256
PEGRatio None
Buchwert None
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 2,23 USD +2,34%
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
106 News & Informationen zur Ocugen Inc Aktie
Zacks.com featured highlights include: Manchester United, Carrols Restaurant, Astronics Corp and Ocugen
Stocks Analysis by Zacks Investment Research covering: Amazon.com Inc, Netflix Inc, Astronics Corporation, Carrols Restaurant Group Inc. Read Zacks Investment Research's latest article on Investing.com
Ocugen, Inc. Announces Initiation of Rolling Submission to
MALVERN, Pa., July 15, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing and…
Why Ocugen Stock Skyrocketed 339% in the First Half of 2021
The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.
Ocugen stock drops as partner's COVID-19 shot undergoes WHO review (NASDAQ:OCGN)
The World Health Organization ((WHO)) has begun the review of the COVID-19 vaccine developed by Bharat Biotech, the partner of Ocugen for the commercialization of the vaccine…
OCGN INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
NEW YORK, July 10, 2021 /PRNewswire/ —
WHY: Rosen Law Firm, a global… | July 10, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. – OCGN
NEW YORK, July 10, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. . Such investors are advised to contact Robert S…. | July 10, 2021
Why Shares of Ocugen Are Dropping Today
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 09, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
OCGN, TEDU & HMPT Investor Alert: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
NEW YORK, July 08, 2021 — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded…
Ocugen (NASDAQ:OCGN): Peripheral Scandals Taint This Expired COVID-19 “Me-Too” Longshot
The vaccination wave has passed Ocugen by. The share price is likely to rot away, like so many excess vaccines on the shelves. Find out how investors should position themselves.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. – OCGN
NEW YORK, July 07, 2021 — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm
NEW YORK, July 07, 2021 — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of…
With COVID-19 Variant Threats Rising, Why Are Vaccine Stocks Falling?
Stock markets moved slightly higher despite general worries.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
/PRNewswire/ –Law Offices of Howard G. Smith reminds investors of the upcoming August 16, 2021 deadline to file a lead plaintiff motion in the case filed on…
Ocugen, Welbilt rise; Talos Energy, Hess fall
Stocks that traded heavily or had substantial price changes Tuesday:
What's Next For Ocugen Stock As It Nears Key Resistance Level?
Ocugen Inc. (NASDAQ:OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner B…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
Investors with losses exceeding $100,000 are encouraged to contact the firm…
Futures On Edge At All Time High As Oil Surges To Highest Since 2014
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
3 Tips for Coronavirus Investing Right Now
Whether you're a cautious or aggressive investor, there's something for you in this space.
One Bright Spot for Ocugen Investors
It may equal some coronavirus vaccine revenue ahead.
India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Phase-III trials of a vaccine made by India’s Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm said…
AstraZeneca : India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Phase-III trials of a vaccine made by
India's Bharat Biotech showed it was 93.4% effective against
severe symptomatic COVID-19, the firm said… | July 3, 2021
Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19 (NASDAQ:OCGN)
Ocugen (OCGN)+13.3% post-market after Indian co-development partner Bharat Biotech shared
Ocugen's COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease
National Institute of Virology . COVAXIN™ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform with an excellent safety track… | July 2, 2021
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, July 02, 2021 — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded…
Ocugen : Opportunity for Investors With Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit – OCGN
Robbins Geller Rudman & Dowd LLP announces purchasers of Ocugen, Inc. securities between February 2, 2021 and June 10, 2021, inclusive have until August 17, 2021 to seek appointment as lead… | July 2, 2021
How Risky Is Ocugen After Its Recent Setback?
The U.S. vaccine market has slipped farther out of reach.
Better Short-Squeeze Stock: Clover Health or Ocugen?
Both have the necessary ingredients for explosive short-squeeze returns.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. – OCGN
/PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN). Such investors are…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. – OCGN
NEW YORK, July 1, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ('Ocugen' or the 'Company') (N…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Ocugen, Inc. – OCGN
NEW YORK, July 1, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN).
Ocugen, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Investors with losses of $100,000 are encouraged to contact the firm before August 17, 2021; click here to submit trade information LOS ANGELES, July 01, 2021 — The Portnoy Law Firm…
Ocugen, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Investors with losses of $100,000 are encouraged to contact the firm before August 17, 2021; click here to submit trade information LOS ANGELES, July …
Why Ocugen Shares Are Slipping Today
It could be due to the aftereffects of being included in a major stock index.
What's Going On With Ocugen (OCGN) Stock Today?
Ocugen Inc (NASDAQ:OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's…
ROSEN, A LEADING LAW FIRM, Encourages Ocugen, Inc. Investors To Secure Counsel Before Important August 17 Deadline In Securities Class Action – OCGN
WHY:Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. OCGN between February 2, 2021 and June 10, 2021,
OCGN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors Of Class Action And Encourages Shareholders To Contact The Firm
Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ocugen, Inc. (“Ocugen” or “the
Is It Too Late to Buy Ocugen Stock?
The company has found a partner to manufacture its COVID-19 vaccine — but will it be all for naught?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”)…